A prospective study of thyroid function, bone loss, and fractures in older men: The MrOS study
Authors:
- Eric S OrwollEOEric S Orwoll
- Douglas C BauerDBDouglas C Bauer
- for the Osteoporotic Fractures in Men (MrOS) StudyFSfor the Osteoporotic Fractures in Men (MrOS) Study
Open Access
- 27 September 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 28 (3) , 472-479
Abstract
Excess thyroid hormone is associated with increased bone loss and fracture risk in older women, but few data exist for men. We sought to determine if thyroid function is independently associated with bone loss and fracture risk in older men. Data were analyzed from the Osteoporotic Fractures in Men (MrOS) study, a cohort of community-dwelling U.S. men aged 65 years and older. Using a case-cohort design, fasting baseline serum archived at −80°C was assayed for thyroid-stimulating hormone (thyrotropin) (TSH) and free thyroxine (FT4) in 397 men with confirmed nonspine fracture, including 157 hip fractures, and 1420 randomly selected men without fracture. TSH and FT4 were analyzed as continuous variables and as thyroid function categories (subclinical hyperthyroid, euthyroid, and subclinical hypothyroid). Hip dual-energy X-ray absorptiometry (DXA) (Hologic QDR4500) was measured at baseline and after a mean follow-up of 4.6 years. Incident nonspine fractures were centrally adjudicated. Bone loss was evaluated with multivariate regression methods and fractures risk was evaluated using hazard models that accounted for the case-cohort sampling, adjusted for age, clinic-site, body mass index (BMI), race, physical activity, corticosteroid use, smoking, alcohol intake, and thyroid medication use. In fully adjusted analyses, TSH was not associated with risk of nonspine fracture (relative hazard [RH] 0.92 per SD decrease in TSH; 95% confidence interval [CI], 0.74–1.14), but was significantly associated with risk of hip fracture (RH 1.31; 95% CI, 1.01–1.71), which persisted among normal range TSH values (RH 1.21; 95% CI, 1.00–1.47). There was no association between TSH or FT4 and bone loss, and fracture risk did not differ significantly by thyroid function category. We conclude that although neither TSH nor FT4 are associated with bone loss, lower serum TSH may be associated with an increased risk of hip fractures in older men. © 2013 American Society for Bone and Mineral Research.Keywords
This publication has 41 references indexed in Scilit:
- Impact of severity, duration, and etiology of hyperthyroidism on bone turnover markers and bone mineral density in menBMC Endocrine Disorders, 2011
- Subclinical hyperthyroidism and dementia: the Sao Paulo Ageing & Health Study (SPAH)BMC Public Health, 2010
- Competing Risk of Death: An Important Consideration in Studies of Older AdultsJournal of the American Geriatrics Society, 2010
- Serum TSH values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral densityBone, 2010
- The Relationship between Serum TSH and Bone Mineral Density in Men and Postmenopausal Women: The Tromsø StudyThyroid®, 2008
- Intermittent recombinant TSH injections prevent ovariectomy-induced bone lossProceedings of the National Academy of Sciences, 2008
- Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study — A large observational study of the determinants of fracture in older menContemporary Clinical Trials, 2005
- Prospective Study of the Spontaneous Course of Subclinical Hypothyroidism: Prognostic Value of Thyrotropin, Thyroid Reserve, and Thyroid AntibodiesThe Journal of Clinical Endocrinology & Metabolism, 2002
- Fractures in Patients with Hyperthyroidism and Hypothyroidism: A Nationwide Follow-Up Study in 16,249 PatientsThyroid®, 2002
- Drug data coding and analysis in epidemiologic studiesEuropean Journal of Epidemiology, 1994